Clinical trial
Study on Optimal Treatment Strategy for Elderly Patients With High-risk Complex Aortic Valve Disease
NCT05044377 is registered in ClinicalTrials.gov with Yongjian Wu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on Optimal Treatment Strategy for Elderly Patients With High-risk Complex Aortic Valve Disease
- Lead sponsor
- Yongjian Wu
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 1, 2021
- Completion date
- December 31, 2022
- Enrollment
- 540 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.